Q2 2023 Holdings
Filed 2023-08-14 | 73 holdings | $365.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr S&P Biotech ETF(XBI) | ETF | 78464A870 | $47.0M | 565,000 | 12.9% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $24.1M | 612,975 | 6.6% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $20.9M | 13,680,554 | 5.7% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $15.9M | 251,521 | 4.3% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $13.7M | 512,285 | 3.7% |
| Ishares Nasdaq Biotech Indx(IBB) | ETF | 464287556 | $13.0M | 102,500 | 3.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $12.1M | 135,212 | 3.3% |
| Morphic Holding Inc | COM | 61775R105 | $11.9M | 206,748 | 3.2% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $11.3M | 479,820 | 3.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $10.9M | 332,734 | 3.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $10.8M | 280,538 | 3.0% |
| Merus N V | COM | N5749R100 | $10.1M | 384,870 | 2.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $9.4M | 450,873 | 2.6% |
| Karuna Therapeutics Inc | COM | 48576A100 | $9.1M | 42,173 | 2.5% |
| Dexcom Inc(DXCM) | COM | 252131107 | $8.7M | 67,552 | 2.4% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $8.5M | 180,306 | 2.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $7.0M | 74,615 | 1.9% |
| Atricure Inc(ATRC) | COM | 04963C209 | $6.2M | 125,529 | 1.7% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $6.1M | 507,100 | 1.7% |
| Dice Therapeutics Inc | COM | 23345J104 | $5.9M | 127,585 | 1.6% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $5.6M | 556,695 | 1.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $5.5M | 611,032 | 1.5% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $5.0M | 496,416 | 1.4% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $4.8M | 293,655 | 1.3% |
| Accuray Inc(ARAY) | COM | 004397105 | $4.7M | 1,222,358 | 1.3% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $4.6M | 225,717 | 1.3% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $4.1M | 1,307,407 | 1.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $4.0M | 519,384 | 1.1% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $4.0M | 569,000 | 1.1% |
| Alector Inc(ALEC) | COM | 014442107 | $3.8M | 638,938 | 1.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $3.8M | 357,784 | 1.0% |
| Ascendis Pharma A/S | NOTE 2.250% 4/0 | 04351PAD3 | $3.6M | $4,000,000 | 1.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $3.4M | 94,700 | 0.9% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $3.1M | 122,200 | 0.9% |
| Axogen Inc(AXGN) | COM | 05463X106 | $3.0M | 332,103 | 0.8% |
| Mediwound LTD(MDWD) | SHS NEW | M68830112 | $2.7M | 257,653 | 0.8% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $2.7M | 110,000 | 0.7% |
| Mersana Therapeutics Inc | COM | 59045L106 | $2.7M | 810,845 | 0.7% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $2.2M | 930,394 | 0.6% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $2.1M | 52,675 | 0.6% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $1.9M | 797,054 | 0.5% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $1.9M | 47,661 | 0.5% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $1.6M | 1,111,049 | 0.4% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $1.6M | 172,308 | 0.4% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $1.5M | 940,582 | 0.4% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $1.5M | 361,084 | 0.4% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $1.3M | 1,009,013 | 0.4% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $1.3M | 98,560 | 0.4% |
| Brainsway LTD(BWAY) | SPONSORED ADS | 10501L106 | $1.2M | 504,681 | 0.3% |
| Sutro Biopharma Inc | COM | 869367102 | $1.1M | 242,779 | 0.3% |